Nonmyeloablative conditioning.
Showing 51 - 75 of 1,422
Type 1 Diabetes Trial in Shanghai (AHSCT, Insulin therapy)
Completed
- Type 1 Diabetes Mellitus
- AHSCT
- Insulin therapy
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University School of Medicine
Nov 16, 2021
Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Denmark, Italy, United
Completed
- Chronic Lymphocytic Leukemia
- +8 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Rochester, Minnesota
- +4 more
Jun 20, 2019
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Cyclophosphamide
- +6 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Denmark, Germany, United States
Completed
- Acute Lymphoblastic Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +6 more
-
Denver, Colorado
- +10 more
Oct 10, 2019
Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)
Recruiting
- Refractory Leukemia
- CALGE-VEN- RIC-MBF
-
Shanghai, Shanghai, China
- +2 more
May 22, 2023
Healthy Trial in Barcelona (Unmasking previous conditioning procedure, No unmasking of previous conditioning)
Completed
- Healthy
- Unmasking previous conditioning procedure
- No unmasking of previous conditioning
-
Barcelona, SpainHospital Vall d'Hebron
May 31, 2023
Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Fludarabine, busulfan and melphalan
- Fludarabine and Busulfan
-
Fuzhou, Fujian, China
- +8 more
Aug 14, 2023
Multiple Myeloma Trial in Montréal (ECT-001 (UM171) expanded cord blood)
Active, not recruiting
- Multiple Myeloma
- ECT-001 (UM171) expanded cord blood
-
Montréal, Quebec, CanadaCIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maiso
Mar 8, 2022
Acute Ischemic Stroke, Reperfusion Injury Trial in Tianjin (Mechanical thrombectomy combined with ischemic post-conditioning)
Recruiting
- Acute Ischemic Stroke
- Reperfusion Injury
- Mechanical thrombectomy combined with ischemic post-conditioning
-
Tianjin, ChinaTianjin Huanhu Hospital
Jun 9, 2023
GVHD Trial run by the NHLBI (Topical Dexamethasone, Placebo)
Completed
- Graft vs Host Disease
- Topical Dexamethasone
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022
Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)
Recruiting
- Acute Leukemia
- mitoxantrone liposome
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 13, 2023
Stroke Trial (Real Ischemic Conditioning, Sham Ischemic Conditioning, Aerobic Exercise)
Not yet recruiting
- Stroke
- Real Ischemic Conditioning
- +2 more
- (no location specified)
Jun 15, 2023
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Reduced-Intensity Conditioning Regimen
- Myeloablative Conditioning Regimen
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Jan 4, 2023
Acute Ischemic Stroke Trial in Tianjin (Mechanical thrombectomy combined with ischemic post-conditioning, Mechanical
Not yet recruiting
- Acute Ischemic Stroke
- Mechanical thrombectomy combined with ischemic post-conditioning
- Mechanical thrombectomy alone
-
Tianjin, Tianjin, ChinaTianjin Huanhu Hospital
Mar 28, 2023
Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)
Completed
- Myeloproliferative Disorders
- +3 more
- anti-thymocyte globulin
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Oct 30, 2020
Hypertension, Vascular Diseases Trial in Derby (Remote Ischaemic Preconditioning, Sham Remote Ischaemic Preconditioning)
Recruiting
- Hypertension
- Vascular Diseases
- Remote Ischaemic Preconditioning
- Sham Remote Ischaemic Preconditioning
-
Derby, Derbyshire, United KingdomSchool of Medicine, Royal Derby Hospital Site, University of Not
Jul 24, 2023
Stroke, Chronic Stroke, Gait, Hemiplegic Trial in Cleveland (Peripheral Nerve Stimulation)
Recruiting
- Stroke
- +4 more
- Peripheral Nerve Stimulation
-
Cleveland, OhioMetroHealth Medical Center
Oct 27, 2023
Carotid Stenosis, Ischemic Stroke Trial in Changchun (remote ischemic conditioning, sham remote ischemic conditioning)
Not yet recruiting
- Carotid Stenosis
- Ischemic Stroke
- remote ischemic conditioning
- sham remote ischemic conditioning
-
Changchun, Jilin, China
- +1 more
Nov 30, 2022
Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)
Recruiting
- Acute Lymphoblastic Leukemia
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Nov 5, 2023
Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)
Recruiting
- Hematological Malignancies
- Total Body Irradiation
- +6 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 4, 2022
Carotid Artery Stenosis Trial in Changchun (Remote ischemic conditioning, Sham remote ischemic conditioning)
Not yet recruiting
- Carotid Artery Stenosis
- Remote ischemic conditioning
- Sham remote ischemic conditioning
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Sep 13, 2023
Remote Ischemic Conditioning Trial in Changchun (Remote ischemic conditioning, Sham remote ischemic conditioning)
Not yet recruiting
- Remote Ischemic Conditioning
- Remote ischemic conditioning
- Sham remote ischemic conditioning
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Jul 25, 2023
Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)
Not yet recruiting
- Severe Aplastic Anemia
- Busulfan
- Flu/Cy/ATG or Cy/ATG
- (no location specified)
Oct 1, 2023
Acute Ischemic Stroke Trial in Changchun (Remote ischemic conditioning, Sham remote ischemic conditioning)
Not yet recruiting
- Acute Ischemic Stroke
- Remote ischemic conditioning
- Sham remote ischemic conditioning
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Jun 20, 2023